These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8293162)

  • 1. Meningioma.
    Kujas M
    Curr Opin Neurol; 1993 Dec; 6(6):882-7. PubMed ID: 8293162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of PDGF, PDGF-receptor, EGF-receptor and sex hormone receptors on meningioma.
    Kuratsu JI; Seto H; Kochi M; Ushio Y
    Acta Neurochir (Wien); 1994; 131(3-4):289-93. PubMed ID: 7754837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical study of progesterone receptor in human meningioma.
    Perrot-Applanat M; Groyer-Picard MT; Kujas M
    Acta Neurochir (Wien); 1992; 115(1-2):20-30. PubMed ID: 1595392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas.
    Pravdenkova S; Al-Mefty O; Sawyer J; Husain M
    J Neurosurg; 2006 Aug; 105(2):163-73. PubMed ID: 17219818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Steroid receptors and atypical histology as prognostic parameters in meningioma].
    Kostron H; Daxenbichler G; Maier H
    Wien Klin Wochenschr; 1990 Sep; 102(18):525-8. PubMed ID: 2264343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular biology of hormone and growth factor receptors in meningiomas.
    Black P; Carroll R; Zhang J
    Acta Neurochir Suppl; 1996; 65():50-3. PubMed ID: 8738495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas.
    Nagashima G; Aoyagi M; Wakimoto H; Tamaki M; Ohno K; Hirakawa K
    Neurosurgery; 1995 Sep; 37(3):478-82; discussion 483. PubMed ID: 7501113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic indicators.
    Sarkar A; Chiocca EA
    J Neurosurg; 2006 Aug; 105(2):161-2; discussion 162. PubMed ID: 17219817
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy.
    Schrell UM; Adams EF; Fahlbusch R; Greb R; Jirikowski G; Prior R; Ramalho-Ortigao FJ
    J Neurosurg; 1990 Nov; 73(5):743-9. PubMed ID: 2213164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestin receptors in meningiomas. Comparison of cytosolic assays with immunocytochemical identification in cryostat and paraffin sections.
    Blaauw G; Koudstaal J; Blankenstein MA; Debets-Te Baerts M; Gijzen AH
    Acta Neurochir (Wien); 1995; 134(1-2):83-7. PubMed ID: 7668135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and progesterone receptors in meningiomas and gliomas.
    Georgakulias N; Singounas E; Kypriades E; Giotis J; Karvounis P
    Zentralbl Neurochir; 1993; 54(3):139-42. PubMed ID: 8237168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of progestin and estrogen receptors in human meningiomas.
    Gabos S; Berkel J
    Neuroepidemiology; 1992; 11(4-6):255-60. PubMed ID: 1291889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics.
    Kolles H; Niedermayer I; Schmitt C; Henn W; Feld R; Steudel WI; Zang KD; Feiden W
    Acta Neurochir (Wien); 1995; 137(3-4):174-81. PubMed ID: 8789658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow up of progesterone receptor status in benign meningioma: a prognostic indicator of recurrence?
    Fewings PE; Battersby RD; Timperley WR
    J Neurosurg; 2000 Mar; 92(3):401-5. PubMed ID: 10701525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features.
    Brandis A; Mirzai S; Tatagiba M; Walter GF; Samii M; Ostertag H
    Neurosurgery; 1993 Aug; 33(2):212-7; discussion 217-8. PubMed ID: 8367042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of androgen and progesterone receptors in primary human meningiomas.
    Maxwell M; Galanopoulos T; Neville-Golden J; Antoniades HN
    J Neurosurg; 1993 Mar; 78(3):456-62. PubMed ID: 8433149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression.
    Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H
    J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactive estrogen receptor protein in meningiomas: comparison with the androgen receptor and progesterone receptor binding activity.
    Lesch KP; Engl HG; Schott W; Gross S
    Zentralbl Neurochir; 1987; 48(2):124-34. PubMed ID: 3314266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for clonal spread in the development of multiple meningiomas.
    Larson JJ; Tew JM; Simon M; Menon AG
    J Neurosurg; 1995 Oct; 83(4):705-9. PubMed ID: 7674021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid growth of a meningioma during pregnancy: relationship with estrogen and progesterone receptors--case report.
    Saitoh Y; Oku Y; Izumoto S; Go J
    Neurol Med Chir (Tokyo); 1989 May; 29(5):440-3. PubMed ID: 2477748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.